首页 > 市场调查报告书 > 製药

神经疾病

市场调查报告书

商品编码

1578245

全球肌萎缩侧索硬化症治疗市场研究报告 - 2024 年至 2032 年产业分析、规模、份额、成长、趋势与预测

Global Amyotrophic Lateral Sclerosis Treatment Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2024 to 2032

出版日期: 2024年09月01日 | 出版商:

Value Market Research | 英文 128 Pages | 商品交期: 最快1-2个工作天内

价格

简介目录图表

全球肌萎缩侧索硬化症治疗市场的需求预计将从2023年的7.7307亿美元达到2032年的近13.4428亿美元，2024-2032年研究期间的复合年增长率为6.34%。

肌萎缩侧索硬化症是一种加速性神经退化性疾病，其中调节中枢神经系统随意肌的神经细胞死亡。在近一半的 ALS 病例中，患者会丧失吞嚥、呼吸、说话、行走和使用双手的能力。肌萎缩侧索硬化症无法治愈，没有有效的治疗方法可以减缓或阻止其病程。儘管没有任何治疗可以消除肌萎缩侧索硬化症造成的损害，但它可以透过减少症状的进展、预防併发症和提高整体生活质量，让人们感到更加安心和独立。 ALS 可以透过物理和职业治疗、沟通帮助、营养支持和呼吸支持来治疗。

市场动态

久坐的生活方式会增加老年人患这种疾病的机会，因此需要开发新的药物和量身定制的治疗方案。预计这些因素将推动肌萎缩侧索硬化症治疗市场走高。肌萎缩侧索硬化症盛行率的成长预计将推动全球肌萎缩侧索硬化症治疗市场的发展。然而，预计该市场将受到高昂的治疗成本、对肌萎缩侧索硬化症缺乏了解以及有限的治疗方案的阻碍。

研究报告涵盖波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰地了解行业结构并评估全球范围内的竞争吸引力。此外，这些工具也对全球肌萎缩侧索硬化症治疗市场的各个细分市场进行了包容性评估。肌萎缩侧索硬化症治疗产业的成长和趋势为本研究提供了整体方法。

市场区隔

肌萎缩侧索硬化症治疗市场报告的这一部分提供了国家和区域层面的细分市场的详细资料，从而帮助策略家确定相应产品或服务的目标人群以及即将到来的机会。

按治疗

药物
干细胞治疗
其他的

按配销通路

医院药房
零售药局
其他的

区域分析

本节涵盖区域前景，重点介绍北美、欧洲、亚太地区、拉丁美洲以及中东和非洲肌萎缩侧索硬化症治疗市场当前和未来的需求。此外，该报告重点关注所有主要地区各个应用领域的需求、估计和预测。

该研究报告还涵盖了市场主要参与者的全面概况以及对全球竞争格局的深入了解。肌萎缩侧索硬化症治疗市场的主要参与者包括田边三菱製药公司、大冢製药有限公司、BrainStorm Therapeutics、Biogen Inc.、Corestem、AB Science、F.Hoffmann-La Roche AG、Biohaven Pharmaceutical、Sun Pharmaceutical 、Ionis製药公司。

如果您有任何客製化要求，请写信给我们。我们的研究团队可以根据您的需求提供客製化报告。

区域展望
介绍
北美销售分析
- 概览、历史与预测资料销售分析
- 北美按细分市场销售分析
- 北美按国家销售分析
- 美国销售分析
- 加拿大销售分析
- 墨西哥销售分析
欧洲销售分析
- 概览、历史与预测资料销售分析
- 欧洲按细分市场销售分析
- 欧洲按国家销售分析
- 英国销售分析
- 法国销售分析
- 德国销售分析
- 义大利销售分析
- 俄罗斯销售分析
- 欧洲其他地区销售分析
亚太地区销售分析
- 概览、历史与预测资料销售分析
- 亚太地区按细分市场销售分析
- 亚太地区按国家销售分析
- 中国销售分析
- 印度销售分析
- 日本销售分析
- 韩国销售分析
- 澳洲销售分析
- 东南亚销售分析
- 亚太地区其他地区销售分析
拉丁美洲销售分析
- 概览、历史与预测资料销售分析
- 拉丁美洲按细分市场销售分析
- 拉丁美洲按国家销售分析
- 巴西销售分析
- 阿根廷销售分析
- 秘鲁销售分析
- 智利销售分析
- 拉丁美洲其他地区销售分析
中东和非洲销售分析
- 概览、历史与预测资料销售分析
- 中东和非洲按细分市场销售分析
- 中东和非洲按国家销售分析
- 沙乌地阿拉伯销售分析
- 阿联酋销售分析
- 以色列销售分析
- 南非销售分析
- 中东其他地区和非洲销售分析

第 8 章：肌萎缩侧索硬化症治疗公司的竞争格局

肌萎缩侧索硬化症治疗市场竞争
伙伴关係/协作/协议
併购
新产品发布
其他发展

第 9 章：公司简介

顶级公司市占率分析
市场集中度
Mitsubishi Tanabe Pharma Corporation

公司概况
公司收入
产品
最新动态

Otsuka Pharmaceutical Co. Ltd.

公司概况
公司收入
产品
最新动态

BrainStorm Therapeutics

公司概况
公司收入
产品
最新动态

Biogen Inc.

公司概况
公司收入
产品
最新动态

Corestem

公司概况
公司收入
产品
最新动态

AB Science

公司概况
公司收入
产品
最新动态

F.Hoffmann-La Roche AG

公司概况
公司收入
产品
最新动态

Biohaven Pharmaceutical

公司概况
公司收入
产品
最新动态

Sun Pharmaceutical

公司概况
公司收入
产品
最新动态

Ionis Pharmaceuticals Inc

公司概况
公司收入
产品
最新动态

註 - 在公司概况中，财务详细资讯和最新发展视情况而定，或对私人公司而言可能不包括在内

简介目录图表

Product Code: VMR11216729

The global demand for Amyotrophic Lateral Sclerosis Treatment Market is presumed to reach the market size of nearly USD 1344.28 Million by 2032 from USD 773.07 Million in 2023 with a CAGR of 6.34% under the study period 2024-2032.

Amyotrophic lateral sclerosis is an accelerating neurodegenerative illness in which nerve cells that regulate voluntary muscles in the central nervous system die. In nearly half of ALS cases, individuals lose the ability to swallow, breathe, speak, walk, and use their hands. Amyotrophic lateral sclerosis is incurable, and no effective treatment can slow or stop its course. Although no treatment can undo the damage caused by amyotrophic lateral sclerosis, it can make people feel more at ease and independent by reducing the progression of symptoms, preventing complications, and improving their overall quality of life. ALS can be treated with physical and occupational therapy, communication assistance, nutritional support, and breathing support.

MARKET DYNAMICS

Adopting a sedentary lifestyle raises the chance of acquiring the disease in the elderly, necessitating the development of new medications and tailored treatment alternatives. These factors are projected to propel the market for amyotrophic lateral sclerosis treatments higher. Growth in the prevalence of amyotrophic lateral sclerosis disease is expected to drive the global amyotrophic lateral sclerosis therapy market. However, the market is expected to be impeded by high treatment costs, a lack of understanding regarding amyotrophic lateral sclerosis disease, and restricted therapy alternatives.

The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of Amyotrophic Lateral Sclerosis Treatment. The growth and trends of Amyotrophic Lateral Sclerosis Treatment industry provide a holistic approach to this study.

MARKET SEGMENTATION

This section of the Amyotrophic Lateral Sclerosis Treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Treatment

Medication
Stem Cell Therapy
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

REGIONAL ANALYSIS

This section covers the regional outlook, which accentuates current and future demand for the Amyotrophic Lateral Sclerosis Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the Amyotrophic Lateral Sclerosis Treatment market include Mitsubishi Tanabe Pharma Corporation, Otsuka Pharmaceutical Co. Ltd., BrainStorm Therapeutics, Biogen Inc., Corestem, AB Science, F.Hoffmann-La Roche AG, Biohaven Pharmaceutical, Sun Pharmaceutical, Ionis Pharmaceuticals Inc. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1. PREFACE

1.1. Report Description
- 1.1.1 Objective
- 1.1.2 Target Audience
- 1.1.3 Unique Selling Proposition (USP) & offerings
1.2. Research Scope
1.3. Research Methodology
- 1.3.1 Market Research Process
- 1.3.2 Market Research Methodology

2. EXECUTIVE SUMMARY

2.1. Highlights of Market
2.2. Global Market Snapshot

3. AMYOTROPHIC LATERAL SCLEROSIS TREATMENT - INDUSTRY ANALYSIS

3.1. Introduction - Market Dynamics
3.2. Market Drivers
3.3. Market Restraints
3.4. Opportunities
3.5. Industry Trends
3.6. Porter's Five Force Analysis
3.7. Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Treatment
- 3.7.2 Market Attractiveness Analysis By Distribution Channel
- 3.7.3 Market Attractiveness Analysis By Region

4. VALUE CHAIN ANALYSIS

4.1. Value Chain Analysis
4.2. Raw Material Analysis
- 4.2.1 List of Raw Materials
- 4.2.2 Raw Material Manufactures List
- 4.2.3 Price Trend of Key Raw Materials
4.3. List of Potential Buyers
4.4. Marketing Channel
- 4.4.1 Direct Marketing
- 4.4.2 Indirect Marketing
- 4.4.3 Marketing Channel Development Trend

5. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY TREATMENT

5.1. Overview By Treatment
5.2. Historical and Forecast Data Analysis By Treatment
5.3. Medication Historic and Forecast Sales By Regions
5.4. Stem Cell Therapy Historic and Forecast Sales By Regions
5.5. Others Historic and Forecast Sales By Regions

6. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL

6.1. Overview By Distribution Channel
6.2. Historical and Forecast Data Analysis By Distribution Channel
6.3. Hospital Pharmacies Historic and Forecast Sales By Regions
6.4. Retail Pharmacies Historic and Forecast Sales By Regions
6.5. Others Historic and Forecast Sales By Regions

7. GLOBAL AMYOTROPHIC LATERAL SCLEROSIS TREATMENT MARKET ANALYSIS BY GEOGRAPHY

7.1. Regional Outlook
7.2. Introduction
7.3. North America Sales Analysis
- 7.3.1 Overview, Historic and Forecast Data Sales Analysis
- 7.3.2 North America By Segment Sales Analysis
- 7.3.3 North America By Country Sales Analysis
- 7.3.4 United States Sales Analysis
- 7.3.5 Canada Sales Analysis
- 7.3.6 Mexico Sales Analysis
7.4. Europe Sales Analysis
- 7.4.1 Overview, Historic and Forecast Data Sales Analysis
- 7.4.2 Europe By Segment Sales Analysis
- 7.4.3 Europe By Country Sales Analysis
- 7.4.4 United Kingdom Sales Analysis
- 7.4.5 France Sales Analysis
- 7.4.6 Germany Sales Analysis
- 7.4.7 Italy Sales Analysis
- 7.4.8 Russia Sales Analysis
- 7.4.9 Rest Of Europe Sales Analysis
7.5. Asia Pacific Sales Analysis
- 7.5.1 Overview, Historic and Forecast Data Sales Analysis
- 7.5.2 Asia Pacific By Segment Sales Analysis
- 7.5.3 Asia Pacific By Country Sales Analysis
- 7.5.4 China Sales Analysis
- 7.5.5 India Sales Analysis
- 7.5.6 Japan Sales Analysis
- 7.5.7 South Korea Sales Analysis
- 7.5.8 Australia Sales Analysis
- 7.5.9 South East Asia Sales Analysis
- 7.5.10 Rest Of Asia Pacific Sales Analysis
7.6. Latin America Sales Analysis
- 7.6.1 Overview, Historic and Forecast Data Sales Analysis
- 7.6.2 Latin America By Segment Sales Analysis
- 7.6.3 Latin America By Country Sales Analysis
- 7.6.4 Brazil Sales Analysis
- 7.6.5 Argentina Sales Analysis
- 7.6.6 Peru Sales Analysis
- 7.6.7 Chile Sales Analysis
- 7.6.8 Rest of Latin America Sales Analysis
7.7. Middle East & Africa Sales Analysis
- 7.7.1 Overview, Historic and Forecast Data Sales Analysis
- 7.7.2 Middle East & Africa By Segment Sales Analysis
- 7.7.3 Middle East & Africa By Country Sales Analysis
- 7.7.4 Saudi Arabia Sales Analysis
- 7.7.5 UAE Sales Analysis
- 7.7.6 Israel Sales Analysis
- 7.7.7 South Africa Sales Analysis
- 7.7.8 Rest Of Middle East And Africa Sales Analysis

8. COMPETITIVE LANDSCAPE OF THE AMYOTROPHIC LATERAL SCLEROSIS TREATMENT COMPANIES

8.1. Amyotrophic Lateral Sclerosis Treatment Market Competition
8.2. Partnership/Collaboration/Agreement
8.3. Merger And Acquisitions
8.4. New Product Launch
8.5. Other Developments

9. COMPANY PROFILES OF AMYOTROPHIC LATERAL SCLEROSIS TREATMENT INDUSTRY

9.1. Top Companies Market Share Analysis
9.2. Market Concentration Rate
9.3. Mitsubishi Tanabe Pharma Corporation
- 9.3.1 Company Overview
- 9.3.2 Company Revenue
- 9.3.3 Products
- 9.3.4 Recent Developments
9.4. Otsuka Pharmaceutical Co. Ltd.
- 9.4.1 Company Overview
- 9.4.2 Company Revenue
- 9.4.3 Products
- 9.4.4 Recent Developments
9.5. BrainStorm Therapeutics
- 9.5.1 Company Overview
- 9.5.2 Company Revenue
- 9.5.3 Products
- 9.5.4 Recent Developments
9.6. Biogen Inc.
- 9.6.1 Company Overview
- 9.6.2 Company Revenue
- 9.6.3 Products
- 9.6.4 Recent Developments
9.7. Corestem
- 9.7.1 Company Overview
- 9.7.2 Company Revenue
- 9.7.3 Products
- 9.7.4 Recent Developments
9.8. AB Science
- 9.8.1 Company Overview
- 9.8.2 Company Revenue
- 9.8.3 Products
- 9.8.4 Recent Developments
9.9. F.Hoffmann-La Roche AG
- 9.9.1 Company Overview
- 9.9.2 Company Revenue
- 9.9.3 Products
- 9.9.4 Recent Developments
9.10. Biohaven Pharmaceutical
- 9.10.1 Company Overview
- 9.10.2 Company Revenue
- 9.10.3 Products
- 9.10.4 Recent Developments
9.11. Sun Pharmaceutical
- 9.11.1 Company Overview
- 9.11.2 Company Revenue
- 9.11.3 Products
- 9.11.4 Recent Developments
9.12. Ionis Pharmaceuticals Inc
- 9.12.1 Company Overview
- 9.12.2 Company Revenue
- 9.12.3 Products
- 9.12.4 Recent Developments

Note - In company profiling, financial details and recent developments are subject to availability or might not be covered in the case of private companies

简介目录图表

LIST OF TABLES

Market Snapshot
Drivers: Impact Analysis
Restraints: Impact Analysis
List of Raw Material
List of Raw Material Manufactures
Analysis By Treatment (USD MN)
Medication Market Sales By Geography (USD MN)
Stem Cell Therapy Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Analysis By Distribution Channel (USD MN)
Hospital Pharmacies Market Sales By Geography (USD MN)
Retail Pharmacies Market Sales By Geography (USD MN)
Others Market Sales By Geography (USD MN)
Global Amyotrophic Lateral Sclerosis Treatment Market Sales By Geography (USD MN)
North America Market Analysis (USD MN)
United States Market Analysis (USD MN)
Canada Market Analysis (USD MN)
Mexico Market Analysis (USD MN)
Europe Market Analysis (USD MN)
Europe Market Estimate By Country (USD MN)
United Kingdom Market Analysis (USD MN)
France Market Analysis (USD MN)
Germany Market Analysis (USD MN)
Italy Market Analysis (USD MN)
Russia Market Analysis (USD MN)
Spain Market Analysis (USD MN)
Rest of Europe Market Analysis (USD MN)
Asia Pacific Market Analysis (USD MN)
China Market Analysis (USD MN)
Japan Market Analysis (USD MN)
India Market Analysis (USD MN)
South Korea Market Analysis (USD MN)
Australia Market Analysis (USD MN)
South East Asia Market Analysis (USD MN)
Rest of Asia Pacific Market Analysis (USD MN)
Latin America Market Analysis (USD MN)
Brazil Market Analysis (USD MN)
Argentina Market Analysis (USD MN)
Peru Market Analysis (USD MN)
Chile Market Analysis (USD MN)
Rest of Latin America Market Analysis (USD MN)
Middle East & Africa Market Analysis (USD MN)
Saudi Arabia Market Analysis (USD MN)
UAE Market Analysis (USD MN)
Israel Market Analysis (USD MN)
South Africa Market Analysis (USD MN)
Rest of Middle East and Africa Market Analysis (USD MN)
Partnership/Collaboration/Agreement
Mergers And Acquisition